Literature DB >> 15173394

The chalcone xanthohumol inhibits triglyceride and apolipoprotein B secretion in HepG2 cells.

Adele Casaschi1, Geoffrey K Maiyoh, Brent K Rubio, Rachel W Li, Khosrow Adeli, Andre G Theriault.   

Abstract

The present study examined the role of xanthohumol (XN), a plant chalcone, on apolipoprotein B (apoB) and triglyceride (TG) synthesis and secretion, using HepG2 cells as the model system. The data indicated that XN decreased apoB secretion in a dose-dependent manner under both basal and lipid-rich conditions (as much as 43% at 15 micromol/L). This decrease was associated with increased cellular apoB degradation. To determine the mechanism underlying this effect, we examined triglyceride availability, a major factor in the regulation of apoB secretion. XN inhibited the synthesis of TG in the microsomal membrane and the transfer of this newly synthesized TG to the microsomal lumen (decreases of 26 and 64%, respectively, under lipid-rich conditions), indicating that TG availability is a determining factor in the regulation of apoB secretion under the experimental conditions. The inhibition of TG synthesis was caused by a reduction in diacylglycerol acyltransferase (DGAT) activity, which corresponded to a decrease in DGAT-1 mRNA expression, but not DGAT-2 expression. Microsomal triglyceride transfer protein (MTP) may also control the rate of TG transfer from the microsomal membrane to the active lumenal pool. XN decreased MTP activity in a dose-dependent manner (as much as 30%). Whether the reduction in TG accumulation in the microsomal lumen is predominantly due to DGAT and/or MTP activity remains unknown. In summary, the data suggest that xanthohumol is a potent inhibitor of apoB secretion.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15173394     DOI: 10.1093/jn/134.6.1340

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  16 in total

1.  Phloridzin reduces blood glucose levels and improves lipids metabolism in streptozotocin-induced diabetic rats.

Authors:  Mahmood Najafian; Mohammad Zareain Jahromi; Mohammad Javad Nowroznejhad; Parastoo Khajeaian; Mohammad Mehdi Kargar; Mehdi Sadeghi; Amir Arasteh
Journal:  Mol Biol Rep       Date:  2011-12-14       Impact factor: 2.316

2.  Pharmacokinetics of xanthohumol and metabolites in rats after oral and intravenous administration.

Authors:  LeeCole Legette; Lian Ma; Ralph L Reed; Cristobal L Miranda; John Mark Christensen; Rosita Rodriguez-Proteau; Jan F Stevens
Journal:  Mol Nutr Food Res       Date:  2011-12-07       Impact factor: 5.914

3.  In vitro screening for antihyperlipidemic activities in foodstuffs by evaluating lipoprotein profiles secreted from human hepatoma cells.

Authors:  Jyunichiro Takahashi; Gen Toshima; Yukie Matsumoto; Fumiko Kimura; Takanobu Kiuchi; Kentaro Hamada; Keishi Hata
Journal:  J Nat Med       Date:  2011-05-12       Impact factor: 2.343

4.  Xanthohumol Improves Diet-induced Obesity and Fatty Liver by Suppressing Sterol Regulatory Element-binding Protein (SREBP) Activation.

Authors:  Shingo Miyata; Jun Inoue; Makoto Shimizu; Ryuichiro Sato
Journal:  J Biol Chem       Date:  2015-07-03       Impact factor: 5.157

5.  Conformational modulation of the farnesoid X receptor by prenylflavonoids: Insights from hydrogen deuterium exchange mass spectrometry (HDX-MS), fluorescence titration and molecular docking studies.

Authors:  Liping Yang; David Broderick; Yan Campbell; Adrian F Gombart; Jan F Stevens; Yuan Jiang; Victor L Hsu; William H Bisson; Claudia S Maier
Journal:  Biochim Biophys Acta       Date:  2016-09-03

6.  Novel quercetin-3-O-glucoside eicosapentaenoic acid ester ameliorates inflammation and hyperlipidemia.

Authors:  Satvir Sekhon-Loodu; Ziaullah Ziaullah; H P Vasantha Rupasinghe; Yanwen Wang; Marianna Kulka; Fereidoon Shahidi
Journal:  Inflammopharmacology       Date:  2015-07-14       Impact factor: 4.473

7.  Lipid lowering effects of Momordica charantia (Bitter Melon) in HIV-1-protease inhibitor-treated human hepatoma cells, HepG2.

Authors:  Pratibha V Nerurkar; Yun Kyung Lee; Ellen H Linden; Steven Lim; Laurel Pearson; Jennifer Frank; Vivek R Nerurkar
Journal:  Br J Pharmacol       Date:  2006-07-03       Impact factor: 8.739

8.  Modification of the cysteine residues in IkappaBalpha kinase and NF-kappaB (p65) by xanthohumol leads to suppression of NF-kappaB-regulated gene products and potentiation of apoptosis in leukemia cells.

Authors:  Kuzhuvelil B Harikumar; Ajaikumar B Kunnumakkara; Kwang S Ahn; Preetha Anand; Sunil Krishnan; Sushovan Guha; Bharat B Aggarwal
Journal:  Blood       Date:  2008-10-24       Impact factor: 22.113

9.  Xanthohumol ameliorates atherosclerotic plaque formation, hypercholesterolemia, and hepatic steatosis in ApoE-deficient mice.

Authors:  Prakash Doddapattar; Branislav Radović; Jay V Patankar; Sascha Obrowsky; Katharina Jandl; Christoph Nusshold; Dagmar Kolb; Nemanja Vujić; Lalit Doshi; Prakash G Chandak; Madeleine Goeritzer; Helmut Ahammer; Gerald Hoefler; Wolfgang Sattler; Dagmar Kratky
Journal:  Mol Nutr Food Res       Date:  2013-05-03       Impact factor: 5.914

Review 10.  The metabolic advantage of tumor cells.

Authors:  Maurice Israël; Laurent Schwartz
Journal:  Mol Cancer       Date:  2011-06-07       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.